open access

Vol 88, No 8 (2017)
Review paper
Published online: 2017-08-31
Get Citation

Venous thromboembolism in obese pregnant women: approach to diagnosis and management

Ann Kinga Malinowski1, Dorota Bomba-Opoń2, Jacqueline Parrish1, Urszula Sarzyńska2, Dan Farine1
DOI: 10.5603/GP.a2017.0083
·
Pubmed: 28930373
·
Ginekol Pol 2017;88(8):453-459.
Affiliations
  1. Department of Obstetrics & Gynecology, Division of Maternal Fetal Medicine Mount Sinai Hospital,, 600 University Ave, ON M5G 1X5 Toronto, Canada
  2. 1st Department of Gynecology & Obstetrics Medical University in Warsaw, Poland, Plac Starynkiewicza 1/3, 02-015 Warsaw, Poland

open access

Vol 88, No 8 (2017)
REVIEW PAPERS Obstetrics
Published online: 2017-08-31

Abstract

Venous thromboembolism (VTE) remains among the leading causes of maternal mortality in the developed world, presenting variably as deep vein thrombosis (DVT), pulmonary embolism (PE) or cerebral vein thrombosis (CVT), among others. Obesity in particular has been recognized as the principal contributing factor to the risk of VTE in pregnancy and with the global increase in the rates of obesity affecting reproductive age women, heightened awareness of the risk and consequences of VTE in this population are vital. Thus, prophylaxis, diagnosis and treatment of VTE in the obese gravida are discussed.

Abstract

Venous thromboembolism (VTE) remains among the leading causes of maternal mortality in the developed world, presenting variably as deep vein thrombosis (DVT), pulmonary embolism (PE) or cerebral vein thrombosis (CVT), among others. Obesity in particular has been recognized as the principal contributing factor to the risk of VTE in pregnancy and with the global increase in the rates of obesity affecting reproductive age women, heightened awareness of the risk and consequences of VTE in this population are vital. Thus, prophylaxis, diagnosis and treatment of VTE in the obese gravida are discussed.

Get Citation

Keywords

venous thromboembolism, deep vein thrombosis, pulmonary embolism, cerebral vein thrombosis, pregnancy, obesity, anticoagulation, low molecular weight heparin

About this article
Title

Venous thromboembolism in obese pregnant women: approach to diagnosis and management

Journal

Ginekologia Polska

Issue

Vol 88, No 8 (2017)

Article type

Review paper

Pages

453-459

Published online

2017-08-31

DOI

10.5603/GP.a2017.0083

Pubmed

28930373

Bibliographic record

Ginekol Pol 2017;88(8):453-459.

Keywords

venous thromboembolism
deep vein thrombosis
pulmonary embolism
cerebral vein thrombosis
pregnancy
obesity
anticoagulation
low molecular weight heparin

Authors

Ann Kinga Malinowski
Dorota Bomba-Opoń
Jacqueline Parrish
Urszula Sarzyńska
Dan Farine

References (56)
  1. Marik PE, Plante LA. Venous thromboembolic disease and pregnancy. N Engl J Med. 2008; 359(19): 2025–2033.
  2. Surveillance of maternal deaths in the UK 2012–14 and lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009–14. The MBBRACE-UK Report.
  3. Kevane B, Donnelly J, D'Alton M, et al. Risk factors for pregnancy-associated venous thromboembolism: a review. J Perinat Med. 2014; 42(4): 417–425.
  4. Rodger M. Pregnancy and venous thromboembolism: 'TIPPS' for risk stratification. Hematology Am Soc Hematol Educ Program. 2014; 2014(1): 387–392.
  5. Benedetto C, Marozio L, Tavella AM, et al. Coagulation disorders in pregnancy: acquired and inherited thrombophilias. Ann N Y Acad Sci. 2010; 1205: 106–117.
  6. Liston F, Davies GAL. Thromboembolism in the obese pregnant woman. Semin Perinatol. 2011; 35(6): 330–334.
  7. Galambosi PJ, Gissler M, Kaaja RJ, et al. Incidence and risk factors of venous thromboembolism during postpartum period: a population-based cohort-study. Acta Obstet Gynecol Scand. 2017; 96(7): 852–861.
  8. Parunov LA, Soshitova NP, Ovanesov MV, et al. Epidemiology of venous thromboembolism (VTE) associated with pregnancy. Birth Defects Res C Embryo Today. 2015; 105(3): 167–184.
  9. Blanco-Molina A, Trujillo-Santos J, Criado J, et al. RIETE Investigators. Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry. Thromb Haemost. 2007; 97(2): 186–190.
  10. Royal College of Obstetricians and Gynaecologists. Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. Green-top Guideline No 37a; 2015:1-40.
  11. Larsen TB, Sørensen HT, Gislum M, et al. Maternal smoking, obesity, and risk of venous thromboembolism during pregnancy and the puerperium: a population-based nested case-control study. Thromb Res. 2007; 120(4): 505–509.
  12. Share of overweight population by sex and age 2014, Overweight and obesity – BMI statistics. European Health Interview Survey, Eurostat, European Commission 2014.
  13. Esmon CT. Basic mechanisms and pathogenesis of venous thrombosis. Blood Rev. 2009; 23(5): 225–229.
  14. Bourjeily G, Paidas M, Khalil H, et al. Pulmonary embolism in pregnancy. Lancet. 2010; 375(9713): 500–512.
  15. Allman-Farinelli MA. Obesity and venous thrombosis: a review. Semin Thromb Hemost. 2011; 37(8): 903–907.
  16. Chan WS, Rey E, Kent NE, et al. VTE in Pregnancy Guideline Working Group, Society of Obstetricians and Gynecologists of Canada. Venous thromboembolism and antithrombotic therapy in pregnancy. J Obstet Gynaecol Can. 2014; 36(6): 527–553.
  17. James AH, Jamison MG, Brancazio LR, et al. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol. 2006; 194(5): 1311–1315.
  18. Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006; 444(7121): 881–887.
  19. Braekkan SK, Siegerink B, Lijfering WM, et al. Role of obesity in the etiology of deep vein thrombosis and pulmonary embolism: current epidemiological insights. Semin Thromb Hemost. 2013; 39(5): 533–540.
  20. Darvall KAL, Sam RC, Silverman SH, et al. Obesity and thrombosis. Eur J Vasc Endovasc Surg. 2007; 33(2): 223–233.
  21. James A. Committee on Practice Bulletins – Obstetrics. Practice bulletin no. 123: Thromboembolism in pregnancy. Obstet Gynecol. 2011; 118(3): 718–729.
  22. Drife J. Deep venous thrombosis and pulmonary embolism in obese women. Best Pract Res Clin Obstet Gynaecol. 2015; 29(3): 365–376.
  23. Marik PE, Plante LA. Venous thromboembolic disease and pregnancy. N Engl J Med. 2008; 359(19): 2025–2033.
  24. Smith SB, Geske JB, Morgenthaler TI. Risk factors associated with delayed diagnosis of acute pulmonary embolism. J Emerg Med. 2012; 42(1): 1–6.
  25. Dresang LT, Fontaine P, Leeman L, et al. Venous thromboembolism during pregnancy. Am Fam Physician. 2008; 77(12): 1709–1716.
  26. Drife J. Thromboembolism. Br Med Bull. 2003; 67(1): 177–190.
  27. Rodger M. Evidence base for the management of venous thromboembolism in pregnancy. Hematology Am Soc Hematol Educ Program. 2010; 2010: 173–180.
  28. Goldhaber S, Visani L, Rosa MDe. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). The Lancet. 1999; 353(9162): 1386–1389.
  29. Le Gal G, Kercret G, Ben Yahmed K, et al. EDVIGE Study Group. Diagnostic value of single complete compression ultrasonography in pregnant and postpartum women with suspected deep vein thrombosis: prospective study. BMJ. 2012; 344: e2635.
  30. Chan WS, Spencer FA, Ginsberg JS. Anatomic distribution of deep vein thrombosis in pregnancy. CMAJ. 2010; 182(7): 657–660.
  31. Royal College of Obstetricians and Gynaecologists. The acute management of thrombosis and embolism during pregnancy and the puerperium. Green-top Guideline No 37b; 2015.
  32. Cook JV, Kyriou J. Radiation from CT and perfusion scanning in pregnancy. BMJ. 2005; 331(7512): 350.
  33. Tan M, Huisman MV. The diagnostic management of acute venous thromboembolism during pregnancy: recent advancements and unresolved issues. Thromb Res. 2011; 127(Suppl 3): S13–S16.
  34. Zuurbier SM, Arnold M, Middeldorp S, et al. Risk of cerebral venous thrombosis in obese women. JAMA Neurol. 2016; 73(5): 579–584.
  35. Saposnik G, Barinagarrementeria F, Brown RD, et al. American Heart Association Stroke Council and the Council on Epidemiology and Prevention. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011; 42(4): 1158–1192.
  36. Cumurciuc R, Crassard I, Sarov M, et al. Headache as the only neurological sign of cerebral venous thrombosis: a series of 17 cases. J Neurol Neurosurg Psychiatry. 2005; 76(8): 1084–1087.
  37. Sidhom Y, Mansour M, Messelmani M, et al. Cerebral venous thrombosis: clinical features, risk factors, and long-term outcome in a Tunisian cohort. J Stroke Cerebrovasc Dis. 2014; 23(6): 1291–1295.
  38. Leach JL, Fortuna RB, Jones BV, et al. Imaging of cerebral venous thrombosis: current techniques, spectrum of findings, and diagnostic pitfalls. Radiographics. 2006; 26(Suppl 1): S19–41; discussion S42.
  39. Bates SM, Greer IA, Middeldorp S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141(2 Suppl): e691S–e736S.
  40. Harenberg J, Schneider D, Heilmann L, et al. Lack of anti-factor Xa activity in umbilical cord vein samples after subcutaneous administration of heparin or low molecular mass heparin in pregnant women. Haemostasis. 1993; 23(6): 314–320.
  41. Flessa HC, Kapstrom AB, Glueck HI, et al. Placental transport of heparin. Am J Obstet Gynecol. 1965; 93(4): 570–573.
  42. Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood. 2005; 106(2): 401–407.
  43. Sanson BJ, Lensing AW, Prins MH, et al. Safety of low-molecular-weight heparin in pregnancy: a systematic review. Thromb Haemost. 1999; 81(5): 668–672.
  44. Pettilä V, Leinonen P, Markkola A, et al. Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin. Thromb Haemost. 2002; 87(2): 182–186.
  45. Schindewolf M, Mosch G, Bauersachs RM, et al. Safe anticoagulation with danaparoid in pregnancy and lactation. Thromb Haemost. 2004; 92(1): 211.
  46. Mazzolai L, Hohlfeld P, Spertini F, et al. Fondaparinux is a safe alternative in case of heparin intolerance during pregnancy. Blood. 2006; 108(5): 1569–1570.
  47. Blickstein D, Blickstein I. The risk of fetal loss associated with Warfarin anticoagulation. Int J Gynaecol Obstet. 2002; 78(3): 221–225.
  48. Della Corte A, De Feo M, Romano G, et al. Risk of warfarin anticoagulation in pregnant patients with mechanical heart valve prostheses. J Heart Valve Dis. 2004; 13(Suppl 1): S90.
  49. Walfisch A, Koren G. The “warfarin window” in pregnancy: the importance of half-life. J Obstet Gynaecol Can. 2010; 32(10): 988–989.
  50. Turrentine MA, Braems G, Ramirez MM. Use of thrombolytics for the treatment of thromboembolic disease during pregnancy. Obstet Gynecol Surv. 1995; 50(7): 534–541.
  51. Leonhardt G, Gaul C, Nietsch HH, et al. Thrombolytic therapy in pregnancy. J Thromb Thrombolysis. 2006; 21(3): 271–276.
  52. Kawamata K, Chiba Y, Tanaka R, et al. Experience of temporary inferior vena cava filters inserted in the perinatal period to prevent pulmonary embolism in pregnant women with deep vein thrombosis. J Vasc Surg. 2005; 41(4): 652–656.
  53. Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med. 1998; 338(7): 409–415.
  54. Miyahara T, Miyata T, Shigematsu K, et al. Clinical outcome and complications of temporary inferior vena cava filter placement. J Vasc Surg. 2006; 44(3): 620–624.
  55. Patel JP, Green B, Patel RK, et al. Population pharmacokinetics of enoxaparin during the antenatal period. Circulation. 2013; 128(13): 1462–1469.
  56. Horlocker T, Wedel D, Rowlingson J, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Reg Anesth Pain Med. 2010; 35(1): 64–101.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl